Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer...

por Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Publicado 2005

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

por Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Publicado 2012